A citation-based method for searching scientific literature

Rui Wang, Haichuan Hu, Yunjian Pan, Yuan Li, Ting Ye, Chenguang Li, Xiaoyang Luo, Lei Wang, Hang Li, Yang Zhang, Fei Li, Yongming Lu, Qiong Lu, Jie Xu, David Garfield, Lei Shen, Hongbin Ji, William Pao, Yihua Sun, Haiquan Chen. J Clin Oncol 2012
Times Cited: 360



Benjamin J Solomon, Lavinia Tan, Jessica J Lin, Stephen Q Wong, Sebastian Hollizeck, Kevin Ebata, Brian B Tuch, Satoshi Yoda, Justin F Gainor, Lecia V Sequist, Geoffrey R Oxnard, Oliver Gautschi, Alexander Drilon, Vivek Subbiah, Christine Khoo, Edward Y Zhu, Michele Nguyen, Dahlia Henry, Kevin R Condroski, Gabrielle R Kolakowski, Eliana Gomez, Joshua Ballard, Andrew T Metcalf, James F Blake, Sarah-Jane Dawson, Wayne Blosser, Louis F Stancato, Barbara J Brandhuber, Steve Andrews, Bruce G Robinson, S Michael Rothenberg. J Thorac Oncol 2020
Times Cited: 107




List of shared articles



Times cited

Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas.
Lorenzo Belluomini, Alice Avancini, Luca Pasqualin, Jessica Insolda, Marco Sposito, Jessica Menis, Daniela Tregnago, Ilaria Trestini, Miriam Grazia Ferrara, Emilio Bria,[...]. Expert Rev Anticancer Ther 2022
1

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.
Martin Pesta, Dattatrya Shetti, Vlastimil Kulda, Tereza Knizkova, Katerina Houfkova, Mahyar Sharif Bagheri, Martin Svaton, Jiri Polivka. Diagnostics (Basel) 2022
0

Non-small-cell lung cancer: how to manage RET-positive disease.
Elisa Andrini, Mirta Mosca, Linda Galvani, Francesca Sperandi, Biagio Ricciuti, Giulio Metro, Giuseppe Lamberti. Drugs Context 2022
1

RET signaling pathway and RET inhibitors in human cancer.
Angelina T Regua, Mariana Najjar, Hui-Wen Lo. Front Oncol 2022
0

RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges.
Alberto Servetto, Daniela Esposito, Roberto Ferrara, Diego Signorelli, Stefania Belli, Fabiana Napolitano, Antonio Santaniello, Paola Ciciola, Luigi Formisano, Roberto Bianco. Biochim Biophys Acta Rev Cancer 2022
0

RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Kalinka. Cancers (Basel) 2022
0

Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer.
Marie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, David Santamaria. Trends Cancer 2021
6

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
C Belli, F Penault-Llorca, M Ladanyi, N Normanno, J-Y Scoazec, L Lacroix, J S Reis-Filho, V Subbiah, J F Gainor, V Endris,[...]. Ann Oncol 2021
34

Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET).
Shinji Takeuchi, Noriko Yanagitani, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio,[...]. Transl Lung Cancer Res 2021
7


Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy.
Federica Zito Marino, Greta Alì, Francesco Facchinetti, Luisella Righi, Gabriella Fontanini, Giulio Rossi, Renato Franco. Expert Rev Anticancer Ther 2021
4

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
4


Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.
Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo. Cancers (Basel) 2021
10

[Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer].
Yujun Zheng, Wei Jiang, Dongyan Chen, Yanjun Li, Lulu Dai, Lei Huang, Mingji Wang. Zhongguo Fei Ai Za Zhi 2021
0


Precision therapy for RET-altered cancers with RET inhibitors.
Kyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, Jie Wu, Vivek Subbiah. Trends Cancer 2021
21

RET Inhibitors in Non-Small-Cell Lung Cancer.
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Agnese Montanino, Raffaele Costanzo, Claudia Sandomenico, Rossella De Cecio,[...]. Cancers (Basel) 2021
11

[Advances in the Treatment of RET Fusion-positive Advanced Non-small Cell Lung Cancer].
Qingyun Gao, Junwei Su, Faman Xiao, Xiaocheng Lin, Jinji Yang. Zhongguo Fei Ai Za Zhi 2021
0